The effects of high inspired concentrations of xenon and krypton on regional CBF (rCBF) were as sessed in the rat using [14Cliodoantipyrine and quantita tive autoradiography, Inhalation of 80% xenon for 1 or 2 min and inhalation of 40% xenon for 2 min were found to have significant effects on rCBF, including average in creases of 75-96% in cerebral neocortical regions, In halation of 40% xenon for 1 min and of 80% krypton for
Summary:
The effects of high inspired concentrations of xenon and krypton on regional CBF (rCBF) were as sessed in the rat using [14Cliodoantipyrine and quantita tive autoradiography, Inhalation of 80% xenon for 1 or 2 min and inhalation of 40% xenon for 2 min were found to have significant effects on rCBF, including average in creases of 75-96% in cerebral neocortical regions, In halation of 40% xenon for 1 min and of 80% krypton for Xenon has many of the characteristics of an ideal agent for measurement of regional CBF (rCBF): (a) Its regional brain concentration can be detected noninvasively using transmission computed tomog raphy (CT); (b) in subjects with normal pulmonary function, its concentration in arterial blood is ac curately reflected in end-tidal gas and can be mea sured noninvasively (Obrist et aI., 1967) ; and (c) it is highly lipid soluble and therefore diffuses readily across brain capillaries, Clinically and scientifically useful results have been obtained with this method (Amano et aI., 1982; Gur et aI., 1982; Yonas et aI. , 1984) , Although the use of xenon CT for rCBF mea surement has so far been limited to several centers, the availability of CT in many hospitals makes this method potentially widely available and therefore clinically relevant.
In high concentrations, xenon is known to have anesthetic effects, The performance of surgery under general anesthesia with 80% xenon was first reported by Cullen and Gross in 195 1. Inhalation of 40-50% xenon is known to produce lightheaded ness, euphoria, paresthesias, a sensation of heavi-ness, changes in the electroencephalogram, and sometimes loss of consciousness (Foley et aI., 1978; Meyer et aI., 198 1; Yonas et aI., 198 1) .
Other anesthetic agents are known to alter CBF. Barbiturates, for example, have consistently been shown to decrease CBF when administered in an esthetic doses (Landau et aI., 1955; Pierce et aI., 1962) , Most studies of the halogenated inhalation anesthetics, including halothane, methoxyflurane, enflurane, and isoflurane, indicate that these agents cause either an increase or no change in CBF (Christensen et aI. , 1967; Theye and Michenfelder, 1968a,b; Michenfelder and Theye, 1973; Cucchiara et aI., 1974; Michenfelder and Cucchiara, 1974; Harp and Hagendal, 1980; Shapiro, 1981) . With a few notable exceptions, studies of anesthetic effects on CBF have not measured regional effects. Landau et al. (1955) found in cats that thiopental decreased rCBF in sensorimotor cortex, auditory cortex, and visual cortex by 38-53% and produced lesser de creases in other brain regions. Ray et al. (1979) measured rCBF in rats anesthetized with halothane and enflurane but reported no significant effects in the regions studied. Dahlgren et al. (198 1) found 70-80% nitrous oxide to alter rCBF significantly in only 6 of 22 brain regions studied in the rat.
Our concern about the pharmacological effects of xenon on rCBF during xenon CT rCBF measure ment prompted us to study the effects of 40 and 80% xenon on rCBF in the rat using [l4C]iodo antipyrine ([14C]IAP) and quantitative auto radiography. Because krypton has been proposed as an alternative to xenon as an agent for CT mea surement of rCBF (Winkler et aI., 1977) , its effects on rCBF were also studied. Preliminary reports of these investigations have been published (Junek et aI. , 1983a,b) .
METHODS
Twenty-eight male Wi star rats were utilized (seven groups of four rats each). Two separate control groups were studied in conjunction with the xenon and krypton experiments. Xenon groups 1 and 2 breathed 40% Xel 40% Ni20% O2 for 1 and 2 min, respectively, whereas xenon groups 3 and 4 breathed 80% Xe/20% O2 for 1 and 2 min, respectively. Animals in the krypton group breathed 80% Kr/20% O2 for 2 min.
The animals were anesthetized with enflurane 0.5-2.0%), nitrous oxide (70%), and oxygen. Both femoral arteries were catheterized with PE-50 polyethylene tubing, and one femoral vein was catheterized with V-2 Silastic or PE-50 polyethylene tubing. Tr acheotomy was performed, and the tracheal mucosa was anesthetized by repeated instillation of 1% lidocaine followed by suc tioning. The tracheotomy tube, which was anchored with a stitch through the tracheal wall, consisted of a Te flon tube 3 cm in length inserted into and glued to a flexible rubber tube, such that the total length was 5 cm and the volume 0.5 ml. While recovering from anesthesia, the an imals were attached to a lead brick with tape placed se curely across the animal's hindquarters and loosely across its thorax. Endotracheal suction was performed at least every 30 min. Body temperature was monitored with a rectal probe and maintained at 37.0 ± OSC with an infrared lamp. At least 2 h was allowed for recovery from anesthesia. Blood pressure was monitored continuously during rCBF measurement in all but two animals, in which a femoral artery catheter clotted.
Shortly before rCBF measurement, the animals were positioned in a guillotine, and endotracheal suction was performed for the final time. The endotracheal tube was connected to a T-tube through which air was flowing at 1.0 Umin; 10 min was allowed for acclimatization. Ar terial pH and blood gas were measured at the start and end of the lO-min period using a Corning model 168 pHI blood gas system. If the Peo2 changed by ",, 3 mm Hg, which was unusual, an additional lO-min acclimatization period was allowed. Control animals continued to breathe air from the T-tube during rCBF measurement. In the xenon and krypton groups, the xenon or krypton flowed through the T-tube at 1.0 Umin. In the animals inhaling xenon or krypton for 2 min, a final arterial blood gas sample was collected after 1.0 (xenon groups 2 and 4) or 1.25 (krypton group) min of gas inhalation. rCBF was measured by a modification of the method described by Sakurada et al. (1978) . Thirty microcuries of r14C]IAP dissolved in 0.3-0.5 ml of 0.0 1 N phosphate in normal saline (pH 7.4) was infused at a constant rate with a Harvard infusion pump. In the xenon groups, the infusion was performed during the final 30 s of gas in halation. Because of the high flows encountered in the xenon-breathing animals, the infusion time was shortened to 20 s in the krypton group to improve the accuracy of rCBF measurement. Immediately prior to [14C]IAP infu sion, a femoral artery catheter partially constricted by a clamp was cut 5.0-5.5 cm from its intravascular end, and the clamp was opened until blood dripped freely from the catheter tip. Two drops of blood were collected on filter paper discs (Whatman 3MM) in 7-13 tared scintillation vials, which were positioned on a manually rotated cir cular platform. The precise timing of blood sampling and decapitation was established with the aid of a tape re corder to an accuracy estimated at 0.1 s or better. After decapitation, the brains were rapidly removed, frozen in Freon chilled on dry ice, mounted on planchettes, and embedded in Lipshaw M-l embedding medium. Twenty micron sections were cut on a Hacker cryostat and promptly dried at 60°C. Blocks of four sections were se lected at 600-to 1 ,000-fJ"m intervals and apposed to x-ray film (Kodak SB-5) for 7 -14 days together with previously calibrated [14C]methyl-methacrylate standards (Amer sham). 14C content in 0. 1-to 2.0-mm 2 regions of interest
was measured with an EyeCom II Vidicon image-pro cessing system. Region of interest values from both sides of the brain from three or four serial 20-fJ"m sections were averaged. Histological examination of adjacent sections stained with hematoxylin and eosin aided the identifica tion of anatomical brain regions. Fifteen milliliters of OCS scintillation cocktail (Amer sham) was added to the vials containing the blood sam ples, which were allowed to stand for 48 h at room tem perature and were shaken several times prior to counting in a Packard Tri-carb liquid scintillation spectrometer. Quench correction was by external standardization. Pre liminary experiments established that the [14C]IAP in blood on the filter paper discs equilibrated completely with the scintillation cocktail within 48 h and that the presence of the filter paper in the vial did not interfere with scintillation counting or quench correction. The transit time of blood through the arterial catheter was calculated, and this lag time (0.5-0.9 s) was subtracted from the recorded time of sample collection. rCBF was calculated as described by Sakurada et al. (1978) using an iterative computer program that solves the convolu tion integral numerically. The value used for the brain blood partition coefficient was 0.8 mllg.
The time required for xenon equilibration was evalu ated in five experiments in two rats. The rats were pre pared in a manner similar to that described above. Partial pressures of xenon and CO2 in gas sampled from a needle inserted into the tracheotomy tube were measured con tinuously and simultaneously during 1 min of 80% xenon inhalation by means of a Nuclide Sectorr mass spectrom eter (Dhawan et al., 1982) . The results ( Fig. 1 ) indicated that equilibration of 80% xenon was complete within 10-15 s. Small decreases in end-tidal Peo2 «5 mm Hg) were observed during 80% xenon inhalation in two of the five measurements.
The rCBF values for the xenon experimental and con trol groups were compared by Duncan's multiple range test (Zar, 1974) , whereas the values for the krypton group were compared with control values by the t test. Loga rithmically transformed data were used for the analyses, as this transformation was found nearly to equalize the variances. Both tests are designed to have a 5% chance of a Type 1 error (finding of a significant difference be tween groups when no difference exists) for each region tested. Because the tests were applied to 26 regions, how-ever, it is likely that Type 1 errors occurred in one or more instances. Thus, undue importance should not be attached to specific instances in which a significant dif ference of p < 0. 05 was found.
RESULTS
The physiological status of control animals and animals breathing xenon or krypton is detailed in Ta ble 1. Arterial blood pH in xenon group 3 differed significantly from that in the other groups. The 3.2 mm Hg mean increase in Pco2 observed during 80% krypton inhalation was significant (p < 0.0 1), whereas the smaller increases in Pco2 during xenon inhalation in groups 2 and 4 were not significant (p > 0.05). None of the other variables differed sig nificantly between groups. No sedation, loss of muscle tone, excitation, or other behavioral effects were consistently observed during xenon or krypton inhalation. reBF values in both xenon controls and krypton controls (Tables 2 and 3 ) are similar to values re ported by Sakurada et al. (1978) for normal animals. The values for the two groups are also similar to each other, with the mean reBF values in the krypton control group averaging 95 ± 8% (mean ± SD) of the corresponding values in the xenon con trol group. As indicated in Ta ble 3, the reBF values differ significantly (p < 0.05) between the two con trol groups in 2 of 26 regions.
reBF values during xenon inhalation are shown in Ta ble 2. Inhalation of 80% xenon produced con sistent and highly significant increases in reBF in cerebral neocortex, with values averaging 175 and 196% of controls at 1 and 2 min, respectively (xenon groups 3 and 4). Most other gray and white matter forebrain regions had lesser increases in reBF. In contrast, most hindbrain structures showed little change in reBF, but significant decreases were seen in some regions in group 4. reBF values in rats breathing 40% xenon for 2 min (group 2) re vealed effects similar to those seen in rats breathing 80% xenon, with reBF in neocortical regions av eraging 181 % of control values. reBF values in rats breathing 40% xenon for 1 min (group 1) were sim ilar to control values in most regions, with values in neocortex averaging 102% of control values.
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" p < 0.01, bp < 0.05 compared with control by multiple range test. , Significant difference from control persists after CO, correction (p < 0.05). d "Dose effect": p < 0.05 comparing 80% xenon groti'ps (groups 3 and 4) with 40% xenon groups (groups I and 2). e "Time effect": p < 0.05 comparing 2-min groups (groups 2 and 4) with I-min groups (groups I and 3). ciated with xenon inhalation could be attributed to pre inhalation differences in Peo2 or to the mild in creases in Peoz during xenon inhalation, a 5%/mm Hg COz correction was applied (Norberg and Siesjo, 1974) , using the Peoz values obtained at 1 min for the animals breathing xenon for 2 min. Sig nificant differences in rCBF from control values re mained evident in many regions following COz cor rection (Table 2) , including the large increases ob served in neocortex.
rCBF values in the krypton group are shown in Table 3 . The values averaged 110% of control values (112% in neocortex). A significant difference from control values was seen in only 3 of 26 regions. Correction for the Peoz values measured at 1.25 min of krypton inhalation by 5%/mm Hg eliminated all significant differences between the two groups.
DISCUSSION
Our results indicate that inhalation of 40 or 80% xenon has large effects on rCBF in many brain re gions of the rat, including marked increases in rCBF in cerebral neocortex. These effects are gen erally greater with 2 min than with 1 min of xenon inhalation.
No other systematic study of the effects of xenon on rCBF has been reported, but other groups have reported preliminary results or indirect evidence. Gur et al. (1982) have reported preliminary results from a study with microspheres in baboons during inhalation of 34% xenon. They found a 5-10% in crease in rCBF within the first 2 min, which appar ently was not statistically significant, followed by a slow and gradual decrease in rCBF after several minutes. Ip (1981) has reported measuring rCBF with 1 33 Xe inhalation and external detectors in a single patient during inhalation of 50% xenon; fast component flow was observed to be increased 56% compared with the values in the same patient during 50% N2 inhalation. Flow values calculated from CT images after several minutes of xenon inhalation have been reported to be lower than those calcu lated from early images (Meyer et aI., 1980; Gur et aI., 1982) , and one group has interpreted this de crease as a pharmacological effect of xenon on rCBF (Meyer et aI., 1980) . However, insofar as these studies included no air-breathing controls, the effects of xenon could not be rigorously evaluated. tissue compartment. A similar phenomenon of de clining flow values with increasing duration of the tracer uptake period has been observed in rCBF measurements with diffusible tracers in animals (EkI6f, 1974) and with HPO and positron emission tomography in humans (Raichle et aI., 1983) . Our results showing large and highly significant effects of xenon on rCBF in the rat indicate the need for similar studies in humans. Clearly, such studies must include measurement in the control state (breathing air) and therefore must utilize a method other than xenon CT for rCBF measure ment. Extrapolation from our results in the rat to possible effects in humans is limited not only by the possibility of interspecies differences in the effects of xenon on the brain, but also by differences in the rate of xenon uptake during continuous inhalation. Because xenon equilibration with arterial blood is complete within 15 s in the rat but requires several minutes in humans (Dhawan et aI., 1982) , effects of xenon on rCBF might be expected to develop more slowly in the latter. Nonetheless, it seems likely that xenon will prove to have effects in humans that are qualitatively similar to those we have described in the rat, since other anesthetic agents, such as barbiturates and halothane, have qualitatively sim ilar effects in many species.
If the effects of inhaled xenon on rCBF in humans are similar to those we observed in the rat, then pharmacological effects of xenon may be an impor tant source of error in xenon CT rCBF studies. However, because we found inhalation of 40% xenon for 1 min (group 1) to have no effect on rCBF in most brain regions, we remain optimistic that xenon will have little or no effect on rCBF during studies employing brief inhalation of �40% xenon.
Inhalation of 80% xenon to equilibrium can be calculated to yield 17 Hounsfield units (HU) of con trast enhancement in gray matter and 30 HU in white matter using the 100-kV p CT technique (VeaH and Mallett, 1965; Kelcz et aI., 1978) . Enhancement of 19 ± 4 and 24 ± 4 HU has been measured in gray and white matter, respectively, during clinical studies employing inhalation of 56 ± 11 % xenon and the 100-kV p technique (Segawa et aI., 1983) . Enhancement of this degree can be measured by CT with acceptable accuracy for rCBF estimation. Inhalation of 80% krypton to equilibrium can be calculated to yield contrast enhancement in gray and white matter of only 4.3 and 5.5 HU, respec tively, at 100 kV p and 3.3 and 4.4 RU, respectively, at 120 kV p (Ingvar and Lassen, 1972; Kitani, 1972) . Studies employing a 5-min inhalation of 80% krypton in humans have yielded � 3 HU of enhance-ment with the 120-kV p technique (D. A. Rottenberg and V. Dhawan, unpublished data), which is not enough for accurate measurement of rCBF using currently available CT scanners. If future improve ments in CT scanner technology lead to an im proved signal-to-noise ratio, krypton CT rCBF studies may become feasible. Our results suggest that the pharmacological effects of krypton on rCBF are likely to be minimal in such studies.
Our study does not indicate the mechanism by which xenon alters rCBF. Barbiturates decrease ce rebral metabolism, resulting in a secondary de crease in CBF (Pierce et aI. , 1962) . The halogenated anesthetics, in contrast, have been shown to exert a vasodilatory effect, resulting in an uncoupling of CBF from the cerebral oxygen metabolism (Chris tensen et aI. , 1967; Theye and Michenfelder, 1968a,b; Michenfelder and Theye, 1973; Cucchiara et aI., 1974; Michenfelder and Cucchiara, 1974; Harp and Hagerdal, 1980) . Because we found that xenon inhalation produced large increases in rCBF in neocortical regions and because no anesthetic agent is known to produce consistent and substan tial increases in cerebral metabolic rate, we think it is likely that xenon, like the halogenated anes thetics, uncouples rCBF from regional metabolism. This might occur either by a direct effect on cere bral resistance vessels or by an effect on cerebral vasoregulatory centers.
Some comments are needed concerning the tech nical aspects of these studies. The method of rCBF calculation assumes that rCBF is not changing during the time that [14C]IAP circulates. Our results indicate that this condition was not met during the xenon experiments. Computer modeling studies, however, show that when linear changes in blood flow occur during [l4C]lAP infusions of �0. 5 min, the calculated values of rCBF are very close to the actual flow at the midpoint of the infusion (L. Junck, unpublished data). Thus, the values we ob tained from 0.5-min [14C]lAP infusions during 1 and 2 min of xenon inhalation are probably close to the actual rCBF values at 0. 75 and 1. 75 min of inhala tion, respectively. Similarly, the values we mea sured from 0. 33-min infusion during 2 min of krypton inhalation are probably close to the actual values at 1.83 min.
Small increases in Pco2 were observed in xenon groups 2 and 4 and in the krypton group, but not in the two rats studied by mass spectrometry. In creases in Pco2 have not been observed during human xenon CT studies (D. A. Rottenberg and V. Dhawan, unpublished data). It is possible that these gases cause mild hypoventilation in the rat by de pressing respiratory control centers. Alternatively, mild hypoventilation might result from respiratory fatigue from the increased work of breathing these heavy gases. The density of 80% xenon (mol wt 131. 3 daltons) is 3. 7 times that of air, whereas the density of 80% krypton (mol wt 83.8 daltons) is 2. 5 times that of air. Since the Reynolds number is di rectly proportional to gas density, the inhalation of a dense gas results in a shift from laminar to tur bulent flow (Slonim and Hamilton, 1976) . Further more, the airway resistance in turbulent flow is di rectly related to gas density. Thus, airway resis tance and the work of breathing are increased during xenon or krypton inhalation. It is possible that this increase in the work of breathing has a central stimulatory effect that is responsible for the increase in rCBF observed in neocortex and other cerebral regions. If this were the case, further studies would be necessary to determine whether a similar effect occurs in humans.
In correcting for the small increase in Pco2, we deliberately chose the relatively large correction factor of 5%/mm Hg, recognizing that the Pco2 values measured at 1 min (xenon groups 2 and 4) or 1.25 min (krypton group) may underestimate the Pco2 values at 1. 5-2. 0 min, when rCBF was mea sured. Furthermore, because this large correction for Pco2 does not eliminate most of the significant differences seen in xenon groups 2 and 4, we are confident that most of the highly significant effects seen with xenon inhalation are not attributable to changes in Pco2.
